The Boston Scientific Ranger Drug-Coated PTA Balloon Catheter (REF H74939670701510) is a paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter designed for the treatment of stenotic lesions in peripheral arteries. Featuring a 7 mm balloon diameter and 150 mm working length, the Ranger DCB combines a low-profile balloon platform with a proprietary drug-excipient coating intended to support sustained luminal patency following dilation.
Key Features
Paclitaxel drug coating with proprietary excipient designed for efficient drug transfer
Balloon diameter: 7 mm
Balloon length: 150 mm
Indicated for percutaneous transluminal angioplasty applications per manufacturer IFU
Low-profile balloon platform engineered for trackability and crossing performance
Compatible guidewire size: Not specified in the located sources
Catheter working length: Not specified in the located sources
Sterile, single-use device
Clinical Applications
Percutaneous transluminal angioplasty of stenotic lesions in peripheral arteries
Treatment of de novo and restenotic lesions in the femoropopliteal segment per labeled indications
Post-dilatation following peripheral interventions where supported by the IFU
Use in vessels with reference diameters consistent with the 7 mm balloon size
Product Information
Brand: Boston Scientific
Product Line: Ranger Drug-Coated Balloon (DCB)
Category: Peripheral Balloon Catheters
REF/UPN: H74939670701510
Balloon Size: 7 mm x 150 mm
Drug Coating: Paclitaxel
Sterility: Sterile, single-use
Packaging: Not specified in the located sources
Regulatory clearances and approved indications vary by region; refer to the official Boston Scientific Instructions for Use for your country before clinical use.